PRESS RELEASE published on 02/02/2023 at 08:00, 3 years 1 month ago Biophytis announces positive final results of the phase 2-3 COVA study with Sarconeos (BIO101) in severe COVID-19
PRESS RELEASE published on 01/31/2023 at 08:00, 3 years 1 month ago Biophytis publishes its financial results for the first half of 2022
PRESS RELEASE published on 01/31/2023 at 08:00, 3 years 1 month ago Biophytis publie ses résultats financiers du 1er semestre 2022
PRESS RELEASE published on 01/19/2023 at 00:00, 3 years 2 months ago Biophytis: Judgment of the Paris Court of Appeal of 17 January 2023 in the case between Biophytis and Negma Group Ltd
PRESS RELEASE published on 01/19/2023 at 00:00, 3 years 2 months ago Biophytis: Arrêt de la Cour d'appel de Paris du 17 janvier 2023 dans l'affaire opposant Biophytis à Negma Group Ltd
PRESS RELEASE published on 01/12/2023 at 08:00, 3 years 2 months ago Biophytis prévoit de prendre les mesures appropriées après avoir reçu l’avis de carence du Nasdaq
PRESS RELEASE published on 01/12/2023 at 08:00, 3 years 2 months ago Biophytis to take appropriate measures after receiving Nasdaq deficiency notice
PRESS RELEASE published on 01/05/2023 at 08:00, 3 years 2 months ago Biophytis annonce sa participation au mois de janvier à deux conférences investisseurs d’importance, aux États-Unis et en France : la JP Morgan Healthcare Conference et le Biomed Event d’In
PRESS RELEASE published on 01/05/2023 at 08:00, 3 years 2 months ago Biophytis announces its participation in two major investor conferences in January, in the United States and in France: the JP Morgan Healthcare Conference and the Invest Securities Biomed
Published on 03/23/2026 at 14:05, 32 minutes ago Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 37 minutes ago BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 1 hour 32 minutes ago SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 2 hours 5 minutes ago Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 2 hours 7 minutes ago Digi Power X to Announce 2025 Year End Financial Results on March 31st
Published on 03/23/2026 at 14:24, 13 minutes ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Published on 03/23/2026 at 14:18, 18 minutes ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited
Published on 03/23/2026 at 08:10, 6 hours 27 minutes ago Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 19 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 19 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 20 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 20 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
